Creating tests to detect the SARS-CoV-2 virus
Official title: Development of SARS-CoV-2 Diagnostics
Funded at Resourcepath, LLC · NIH-11202795 · Data updated 2026-11-12
This study is working on new tests to quickly and accurately detect the COVID-19 virus in people, helping ensure that patients get the right treatment when they need it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Resourcepath, LLC NIH-funded |
| Lab location | 1 site (Sterling, United States) |
| Project start | June 20, 2023 |
| Project end | June 19, 2030 |
| Funding year | 2024 |
| Award (this year) | $746,197 |
| NIH project number | 75N93023D00018-0-759302400001-1 |
| Project ID | NIH-11202795 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who may be experiencing symptoms of COVID-19 or have been exposed to the virus.
✕Less likely to help
Patients who have already recovered from COVID-19 and are not experiencing any symptoms may not receive direct benefits from this research.
What this research studies
This research focuses on developing diagnostic tests for the SARS-CoV-2 virus, which causes COVID-19. It aims to create reliable assays that can detect and identify this infectious agent in humans. The approach involves using advanced techniques to ensure the tests are accurate and effective in various settings. Patients may benefit from improved diagnostic capabilities that can lead to timely treatment and management of COVID-19.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and accessible testing for COVID-19, improving patient outcomes.
How similar studies have gone: Previous research has shown success in developing diagnostic tests for infectious diseases, indicating a strong potential for this approach.
Where this research is happening
-
Resourcepath, LLC
Sterling, United States Active
Researchers
- Principal investigator: Hill, Dana Ashley — Resourcepath, LLC
- Study coordinator: Hill, Dana Ashley
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.